Technetium (99mTc) medronic acid
From Wikipedia, the free encyclopedia
 |
|
|---|---|
| Systematic (IUPAC) name | |
| Methylenebis(phosphonic acid) technetium (99mTc) | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Routes | intravenous |
| Identifiers | |
| ATC code | V09BA02 |
| PubChem | CID 157443 |
| Chemical data | |
| Formula | CH6O6P2 • x99mTc |
| Mol. mass | unknown |
 (what is this?) (verify) |
|
Technetium (99mTc) medronic acid is a pharmaceutical product used in nuclear medicine to localize bone metastases[citation needed] as well as other diseases that can alter the natural turn-over in the bone.[1]
Chemistry [edit]
The drug is a complex of medronic acid, the simplest bisphosphonate, with technetium-99m (99mTc), a radionuclide that emits gamma rays. The exact structure of the complex is not known.[1][2]
References [edit]
|
||||||||||||||||||||||||||||||||
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
